Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2010
10/21/2010WO2010118482A2 Active substances -carrying veterinary composition
10/21/2010WO2010118461A1 Gel compositions for administration of pharmaceutically active compounds
10/21/2010WO2010095964A4 A method for amphiphilic drug loading in liposomes by ion gradient
10/21/2010WO2010092163A3 Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
10/21/2010WO2010091683A3 Device and method for producing pharmaceutically highly refined particles and for coating said particles in microreactors
10/21/2010WO2010089443A3 PHARMACEUTICAL COMPOSITIONS COMPRISING TGF- β1 INHIBITOR PEPTIDES
10/21/2010WO2010080764A3 Pharmaceutical dosages delivery system
10/21/2010WO2010077004A3 Random access scheme for user equipment
10/21/2010WO2010074992A3 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
10/21/2010WO2010071321A3 ORAL FORMULATIONS CONTAINING METFORMIN AND α-GLYCOSIDASE INHIBITOR, AND PREPARATION METHOD THEREOF
10/21/2010WO2010068866A3 Therapeutic particles suitable for parenteral administration and methods of making and using same
10/21/2010WO2010065843A3 Biologic scaffold for prevention of pulmonary fibrosis
10/21/2010WO2010060811A3 Hydrophobins as surface active proteins as excipients in solid pharmaceutical formulations
10/21/2010WO2010056065A3 Method for preparing microspheres and microspheres produced thereby
10/21/2010WO2010033954A3 Fixed dose combination in form of a bilayered or monolayered tablet of aliskiren and amlodipine
10/21/2010WO2010022326A3 Transdermal delivery of apomorphine using microneedles
10/21/2010WO2010015709A3 Fibrous surface structure containing active ingredients with controlled release of active ingredients, use thereof and method for the production thereof
10/21/2010WO2010015419A3 Continuous fiber layer comprising an active substance on the basis of bio-polymers, the use thereof, and method for the production thereof
10/21/2010WO2009138477A3 Epithelial delivery
10/21/2010WO2009068708A8 Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof
10/21/2010US20100268288 Electrical devices and anti-scarring agents
10/21/2010US20100268191 Drug Delivery Catheter using Frangible Microcapsules and Delivery Method
10/21/2010US20100267924 Phosphorus-Containing Compounds with Polymeric Chains, and Methods of Making and Using the Same
10/21/2010US20100267799 Orodispersible pharmaceutical composition of perindopril
10/21/2010US20100267789 Tablet formulations comprising valsartan
10/21/2010US20100267758 Pharmaceutical formulation
10/21/2010US20100267693 Orodispersible pharmaceutical composition of ivabradine
10/21/2010US20100267664 Ophthalmic compositions containing polysaccharide-borate gelling system
10/21/2010US20100267189 Solution-based fabrication of photovoltaic cell
10/21/2010US20100266706 Oral particulate antitumor preparation
10/21/2010US20100266705 Nanoparticulate megestrol formulations
10/21/2010US20100266704 Octreotide depot formulation with constantly high exposure levels
10/21/2010US20100266703 Novel powder and its method of manufacture
10/21/2010US20100266702 Particles containing an active agent in the form of a co-precipitate
10/21/2010US20100266701 Anti-misuse microparticulate oral drug form
10/21/2010US20100266700 Use of adsorbent carbon microspheres for the treatment of irritable bowel syndrome
10/21/2010US20100266699 Pharmaceutical Suspensions and Related Methods
10/21/2010US20100266698 Use of insulin for the treatment of cartilaginous disorders
10/21/2010US20100266697 Mixed ligand surface-modified nanoparticles
10/21/2010US20100266696 Organic Compounds
10/21/2010US20100266695 Multivalent clustering targeting strategy for drug carriers
10/21/2010US20100266694 Chitosan/Carbon Nanotube Composite Scaffolds for Drug Delivery
10/21/2010US20100266693 Controlled release local anesthetic comprising a biologically active non-sulfated glycosaminoglycan matrix
10/21/2010US20100266692 Nanoparticles comprising a non-ionizable polymer and an anionic cellulosic polymer
10/21/2010US20100266691 Agents and Methods to Stimulate Bone Healing
10/21/2010US20100266689 Tissue Augmentation With Active Agent For Wound Healing
10/21/2010US20100266688 Anti-bacterial composition and method for producing the same
10/21/2010US20100266687 Improved tablet coating
10/21/2010US20100266686 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
10/21/2010US20100266685 Seamless Coated Spherical Filled Capsules
10/21/2010US20100266684 Method and composition for administering an nmda receptor antagonist to a subject
10/21/2010US20100266683 New self emulsifying drug delivery system
10/21/2010US20100266682 Polyethylene glycol-coated sodium carbonate as a pharmaceutical excipient and compositions produced from the same
10/21/2010US20100266681 Fatty acid alcohols
10/21/2010US20100266680 Treatment of Cancer Using TLR3 Agonists
10/21/2010US20100266679 Crystalline modifications of n-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino- (l)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof
10/21/2010US20100266678 Cholesterol level lowering liposomes
10/21/2010US20100266677 Nucleic acid binding compounds and methods of use
10/21/2010US20100266676 Nanocapsules with a liquid lipid core charged with water-soluble or water-dispersible active agents
10/21/2010US20100266675 Lipoproteins, lipopeptides and analogs, and methods for making and using them
10/21/2010US20100266674 L-oddc prodrugs for cancer
10/21/2010US20100266673 Compositions and methods for the delivery of nitric oxide
10/21/2010US20100266672 Vaccines
10/21/2010US20100266671 Device and Method for Treating Dermal Tissue
10/21/2010US20100266670 Transdermally absorptive preparation
10/21/2010US20100266669 Multi-zone films
10/21/2010US20100266668 Manufacturing Dissolvable Dosage Forms
10/21/2010US20100266667 Mucosal bioadhesive slow release carrier for delivering active principles
10/21/2010US20100266666 Chewing Gum Tablet And Method Of Dosing Pharmaceutically Active Ingredients In Such Chewing Gum Tablet
10/21/2010US20100266665 Fenugreek Flour for Incorporating Into Food Products
10/21/2010US20100266657 Preformed drug-eluting device to be affixed to an anterior spinal plate
10/21/2010US20100266655 Sustained delivery formulations of risperidone compounds
10/21/2010US20100266654 Medical composition including an extracellular matrix particulate
10/21/2010US20100266651 Emulsifier including glycerin-modified organopolysiloxanes
10/21/2010US20100266645 Pharmaceutical compositions
10/21/2010US20100266644 Methods and compositions for administration of iron
10/21/2010US20100266643 Pulmonary and nasal delivery of serum amyloid p
10/21/2010US20100266547 Methods and compositions for treatment of interferon-resistant tumors
10/21/2010US20100266513 Amphiphilic polymeric material
10/21/2010US20100266512 Crosslinked hyaluronic acid in emulsion
10/21/2010US20100266511 Pharmaceutical foam
10/21/2010US20100266510 Foamable Vehicle and Pharmaceutical Compositions Thereof
10/21/2010US20100266509 Heteroaryl amide analogues as p2x7 antagonists
10/21/2010US20100266491 System for targeted delivery of therapeutic agents
10/21/2010DE69229688C5 Ophthalmische Zusammensetzungen, die Kombinationen von einem Carboanhydrase-Inhibitor und einem Beta-adrenergischen Antagonist enthalten Containing ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist
10/21/2010DE202010010638U1 Nano-Hydrogele für die therapeutische und nichttherapeutische Behandlung, insbesondere zur Therapie von Stresszuständen und Regeneration Nano-hydrogels for the therapeutic and non-therapeutic treatment, in particular for the treatment of stress conditions and regeneration
10/21/2010DE202006020892U1 Partialglyceride als Schmiermittel für pharmazeutische Zusammensetzungen enthaltend Thieno[3,2-c]pyridin-Derivate Partial glycerides as a lubricant for pharmaceutical compositions containing thieno [3,2-c] pyridine derivatives
10/21/2010DE102009002415A1 Emulgator enthaltend glycerinmodifizierte Organopolysiloxane Emulsifier containing glycerol-modified organopolysiloxane
10/21/2010CA2795611A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it
10/21/2010CA2770556A1 Tablets comprising a taste masking agent
10/21/2010CA2767044A1 Drug delivery system and methods of use
10/21/2010CA2758907A1 Polysaccharide derivative and hydrogel thereof
10/21/2010CA2758865A1 Herbal compositions and methods for enhancing vital energy and athletic performance
10/21/2010CA2758858A1 Aqueous ophthalmic compositions containing anionic therapeutic agents
10/21/2010CA2758847A1 Bioavailable capsule compositions of amorphous alpha-(n-sulfonamido)acetamide compound
10/21/2010CA2758820A1 Targeted sustained-release microsphere of vascular occlusive agent containing sodium alginate and sorafenib, production method and use thereof
10/21/2010CA2758754A1 Formulation for stabilizing proteins, which is free of mammalian excipients
10/21/2010CA2758746A1 Gel compositions for administration of pharmaceutically active compounds
10/21/2010CA2758709A1 Bioavailable compositions of amorphous alpha-(n-sulfonamido)acetamide compound
10/21/2010CA2758620A1 Method of producing microbeads
1 ... 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 ... 2991